Medpace Holdings (MEDP) Total Non-Current Liabilities (2015 - 2026)

Medpace Holdings has reported Total Non-Current Liabilities for 12 years, with the latest figure at $1.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 17.62% year-over-year to $1.5 billion; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (up 17.62% YoY), and the FY2025 full-year result was $1.5 billion, up 18.35% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $1.5 billion, up from $1.5 billion in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $1.5 billion in Q1 2026, with the low at $722.1 million in Q1 2022.
• Historically, Total Non-Current Liabilities has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2024.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 68.68% — and 2023, when it fell 2.17%.
• Medpace Holdings' Total Non-Current Liabilities stood at $943.4 million in 2022, then increased by 13.38% to $1.1 billion in 2023, then rose by 15.23% to $1.2 billion in 2024, then climbed by 18.35% to $1.5 billion in 2025, then increased by 0.85% to $1.5 billion in 2026.
• The last three Total Non-Current Liabilities figures came in at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.